Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

Although high-dose cisplatin is the standard regimen of concurrent chemoradiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (HNSCC), varying levels of patient tolerance towards cisplatin have been reported, and the predictive factors of cisplatin tolerance remain to be elu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Clin Oncol
Hlavní autoři: NAKANO, KENJI, SATO, YASUYOSHI, TOSHIYASU, TAKASHI, SATO, YUKIKO, INAGAKI, LINA, TOMOMATSU, JUNICHI, SASAKI, TORU, SHIMBASHI, WATARU, FUKUSHIMA, HIROFUMI, YONEKAWA, HIROYUKI, MITANI, HIROKI, KAWABATA, KAZUYOSHI, TAKAHASHI, SHUNJI
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734196/
https://ncbi.nlm.nih.gov/pubmed/26893880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.687
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky